Alexion Pharmaceuticals (ALXN)
|
93.66
+0.99 (+1.07%)
|
|
|
|
ALXN analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ALXN price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
ALXN earnings
Date
Actual
Expected
Prev Yr Qtr
10/24/2012
0.60
0.47
0.37
7/25/2012
0.47
0.37
0.29
4/24/2012
0.45
0.39
0.30
Alexion Pharmaceuticals (ALXN) Upgrades
Date
Analyst
Old Rating
New Rating
01/18/2011
Gleacher & Co.
Neutral
Buy
09/22/2010
Bernstein
Market Perform
Outperform
06/03/2010
Oppenheimer
Market Perform
Outperform PT $ 62
09/01/2009
Citi
Hold
Buy
04/30/2008
S& P Equity Research
Hold
Buy
Alexion Pharmaceuticals (ALXN) Downgrades
Date
Analyst
Old Rating
New Rating
01/07/2011
UBS
Buy
Neutral PT $ 85
02/15/2008
Wachovia
Outperform
Market Perform
08/08/2007
Credit Suisse
Outperform
Neutral
Alexion Pharmaceuticals (ALXN) New Coverage
Date
Analyst
Rating
11/09/2012
Guggenheim
Buy
08/24/2012
ThinkEquity
Hold
08/07/2012
Lazard Capital
Neutral
03/26/2012
Canaccord Genuity
Buy
11/12/2010
Baird
Neutral
10/18/2010
Gleacher & Co
Neutral
